A Verification Study of JNS020QD in Patients With Osteoarthritis or Low Back Pain

Trial Profile

A Verification Study of JNS020QD in Patients With Osteoarthritis or Low Back Pain

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Back pain; Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutical KK
  • Most Recent Events

    • 06 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Mar 2010 Actual patient number changed from 148 to 151 as reported by ClinicalTrials.gov.
    • 02 Dec 2009 Patient numbers amended from 135 to 148 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top